• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    FIGS Releases Fourth Quarter and Full Year 2024 Financial Results

    2/27/25 4:05:00 PM ET
    $FIGS
    Apparel
    Consumer Discretionary
    Get the next $FIGS alert in real time by email

    2024 Results Exceed Expectations with Net Revenues Growth of 1.8% YoY, Net Income Margin of 0.5%, and Adjusted EBITDA Margin of 9.3%

    Increases Share Repurchase Authorization by $50 Million

    FIGS, Inc. (NYSE:FIGS) (the "Company"), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its fourth quarter and full year 2024 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/.

    Fourth Quarter 2024 Financial Highlights

    • Net revenues were $151.8 million, an increase of 4.8% year over year, primarily due to an increase in orders from existing customers.
      • Scrubwear net revenues were $114.7 million, an increase of 2.4% year over year.
      • Non-scrubwear net revenues were $37.2 million, an increase of 12.8% year over year.
      • U.S. net revenues were $127.5 million, a decrease of 0.5% year over year.
      • International net revenues were $24.3 million, an increase of 45.2% year over year.
    • Gross margin was 67.3%, a decrease of 20 basis points year over year, primarily due to product mix shifts, partially offset by a benefit from duty drawback claims.
    • Operating expenses were $93.3 million, an increase of 11.6% year over year. As a percentage of net revenues, operating expenses increased to 61.4% from 57.7% in the same period last year, primarily due to higher operational costs at our new fulfillment center, higher shipping costs, and lapping the outsized favorable impact in Q4 2023 as a result of the inception of our duty reclassification method last year.
    • Net income and net income, as adjusted(1) were $1.9 million (or $0.01 in diluted earnings per share), a decrease of $8.1 million year over year as compared to net income and net income, as adjusted(1) in the same period last year.
    • Net income margin(2) was 1.2%, as compared to 6.9% in the same period last year.
    • Adjusted EBITDA(1) was $21.1 million, a decrease of $5.5 million year over year.
    • Adjusted EBITDA margin(1)(2) was 13.9%, as compared to 18.4% in the same period last year.

    "We finished the year with solid momentum, as our fourth quarter results exceeded our expectations and were powered by an impactful flow of product newness driving repeat frequency," said Trina Spear, Chief Executive Officer and Co-Founder. "While overall 2024 financial results were mixed, we look forward to seeing our industry and Company normalize coming out of the COVID overhang that impacted us over the past couple years. We intend to accelerate our strategic pillars to drive long-term sustainable and profitable growth through product innovation, deep connection with our community, and meeting our healthcare professionals where they are, both online and offline. We remain confident in our brand positioning, our strategic focus, and the long-term structural strength of the healthcare industry."

    Full Year 2024 Financial Highlights

    • Net revenues were $555.6 million, an increase of 1.8% year over year, primarily driven by an increase in orders from existing customers, partially offset by a decrease in average order value ("AOV").(3)
      • Scrubwear net revenues were $445.1 million, an increase of 1.2% year over year.
      • Non-scrubwear net revenues were $110.4 million, an increase of 4.5% year over year.
      • U.S. net revenues were $474.3 million, a decrease of 1.9% year over year.
      • International net revenues were $81.3 million, an increase of 30.6% year over year.
    • Gross margin was 67.6%, a decrease of 150 basis points year over year, primarily due to product mix shifts.
    • Operating expenses were $373.4 million, an increase of 8.9% year over year. As a percentage of net revenues, operating expenses increased to 67.2% from 62.8% in the same period last year, primarily due to higher digital and brand marketing expenses related to our 2024 Olympics campaign and higher transitory expenses associated with the transition to our new fulfillment center.
    • Net income was $2.7 million and diluted earnings per share was $0.02.
    • Net income margin(2) was 0.5%, as compared to 4.1% in the same period last year.
    • Net income, as adjusted(1) was $2.7 million and diluted earnings per share, as adjusted(1) was $0.02.
    • Adjusted EBITDA(1) was $51.8 million, a decrease of $34.2 million year over year.
    • Adjusted EBITDA margin(1)(2) was 9.3%, as compared to 15.8% in the same period last year.
    • Free Cash Flow(1) was $64.1 million.

    Full Year 2024 Key Operating Metrics

    • Active customers(3) as of December 31, 2024 increased 3.0% year over year to 2.7 million.
    • Net revenues per active customer(3) was $208, a decrease of 1.0% year over year.
    • AOV(3) was $113, a decrease of 1.7% year over year primarily driven by lower units per transaction.

    Increase to Share Repurchase Authorization

    As of December 31, 2024, the Company had approximately $4.6 million available for future repurchases under the Company's ongoing share repurchase program for its outstanding Class A common stock. On February 27, 2025, the Company's Board of Directors authorized a $50.0 million increase in the share repurchase program.

    Under the program, the Company may repurchase shares in the open market, through privately negotiated transactions, by entering into structured repurchase agreements with third parties, by making block purchases, entering into derivatives contracts and/or pursuant to Rule 10b5-1 trading plans, subject to market conditions, applicable securities laws and other legal requirements and relevant factors. The Company is not obligated to repurchase any specific number of shares and the program may be modified, suspended or terminated at any time, without prior notice. The timing, manner, price and amount of any repurchases will be determined at the Company's discretion, subject to business, economic and market conditions and other factors. The share repurchase program has no expiration date.

    Full Year 2025 Financial Outlook

    Net Revenues growth vs. 2024

    down low-single-digits

     

     

    Adjusted EBITDA Margin(2)(4)

    9.0% to 9.5%

    Sarah Oughtred, Chief Financial Officer, commented, "We ended 2024 in a strong financial position that will support our efforts to take decisive actions across a number of measures in 2025. This includes investing with conviction and speed into our emerging channels to accelerate growth over the long term, as well as opportunities across brand and marketing to reinvigorate our customer funnel. At the same time, we are planning a reduction in our reliance on promotions, which we expect will negatively impact our near-term top-line performance but support the longer-term health of the brand. In tandem with these actions, our strong balance sheet and cash flow also support our efforts to return value to shareholders, and we are announcing a $50 million increase in our share repurchase program. We see an incredible opportunity ahead for the brand and believe these actions and discipline are paramount to driving our growth ambitions."

    (1)

     

    "Net income, as adjusted," "adjusted EBITDA," "adjusted EBITDA margin," "diluted earnings per share, as adjusted" and "free cash flow" are non-GAAP financial measures. Please see the sections titled "Non-GAAP Financial Measures and Key Operating Metrics" and "Reconciliations of GAAP to Non-GAAP Measures" below for more information regarding the Company's use of non-GAAP financial measures and reconciliations to the most directly comparable GAAP measures.

    (2)

     

    "Net income margin" and "adjusted EBITDA margin" are calculated by dividing net income and adjusted EBITDA by net revenues, respectively.

    (3)

     

    "Active customers," "net revenues per active customer" and "average order value" are key operational and business metrics that are important to understanding the Company's performance. Please see the sections titled "Non-GAAP Financial Measures and Key Operating Metrics" and "Key Operating Metrics" below for information regarding how the Company calculates its key operational and business metrics and for comparisons of active customers, net revenues per active customer and average order value to the prior year period.

    (4)

     

    The Company has not provided a quantitative reconciliation of its adjusted EBITDA margin outlook to a GAAP net income margin outlook because it is unable, without making unreasonable efforts, to project certain reconciling items. These items include, but are not limited to, future stock-based compensation expense, income taxes, expenses related to non-ordinary course disputes, and transaction costs. These items are inherently variable and uncertain and depend on various factors, some of which are outside of the Company's control or ability to predict. For more information regarding the Company's use of non-GAAP financial measures, please see the section titled "Non-GAAP Financial Measures and Key Operating Metrics."

    Conference Call Details

    FIGS management will host a conference call and webcast today at 2:00 p.m. PT / 5:00 p.m. ET to discuss the Company's financial and business results and outlook. To participate, please dial 1-833-470-1428 (US) or 1-404-975-4839 (International) and the conference ID 686323. The call is also accessible via webcast at ir.wearfigs.com. A recording will be available shortly after the conclusion of the call until 11:59 p.m. ET on March 6, 2025. To access the replay, please dial 1-866-813-9403 (US) or 1-929-458-6194 (International) and the conference ID 185176. An archive of the webcast will be available on FIGS' investor relations website at ir.wearfigs.com.

    Non-GAAP Financial Measures and Key Operating Metrics

    In addition to the GAAP financial measures set forth in this press release, the Company has included non-GAAP financial measures within the meaning of Regulation G and Item 10(e) of Regulation S-K. The Company uses "net income, as adjusted," "diluted earnings per share, as adjusted," "adjusted EBITDA" and "adjusted EBITDA margin" to provide useful supplemental measures that assist in evaluating its ability to generate earnings, provide consistency and comparability with its past financial performance and facilitate period-to-period comparisons of its core operating results as well as the results of its peer companies. The Company uses "free cash flow" as a useful supplemental measure of liquidity and as an additional basis for assessing its ability to generate cash. The Company calculates "net income, as adjusted," as net income adjusted to exclude transaction costs, expenses related to non-ordinary course disputes, other than temporary impairment of held-to-maturity investments, stock-based compensation, including expense related to award modifications, accelerated performance awards and associated payroll taxes and costs, ambassador grants in connection with its initial public offering, and expense resulting from the retirement of a former CFO of the Company, and the income tax impact of these adjustments. The Company calculates "diluted earnings per share, as adjusted" as net income, as adjusted divided by diluted shares outstanding. The Company calculates "adjusted EBITDA" as net income adjusted to exclude: other income (loss), net; gain/loss on disposal of assets; provision for income taxes; depreciation and amortization expense; stock-based compensation and related expense; transaction costs; and expenses related to non-ordinary course disputes. The Company calculates "adjusted EBITDA margin" by dividing adjusted EBITDA by net revenues. The Company calculates "free cash flow" as net cash (used in) provided by operating activities reduced by capital expenditures, including purchases of property and equipment and capitalized software development costs.

    Reconciliations of non-GAAP financial measures to the most directly comparable GAAP measures are included below under the heading "Reconciliations of GAAP to Non-GAAP Measures."

    The Company has also included herein "active customers," "net revenues per active customer" and "average order value," which are key operational and business metrics that are important to understanding Company performance. The Company believes the number of active customers is an important indicator of growth as it reflects the reach of the Company's digital platform, brand awareness and overall value proposition. The Company defines an active customer as a unique customer account that has made at least one purchase in the preceding 12-month period. In any particular period, the Company determines the number of active customers by counting the total number of customers who have made at least one purchase in the preceding 12-month period, measured from the last date of such period. The Company believes measuring net revenues per active customer is important to understanding engagement and retention of customers, and as such, the value proposition for its customer base. The Company defines net revenues per active customer as the sum of total net revenues in the preceding 12-month period divided by the current period active customers. The Company defines average order value as the sum of the total net revenues in a given period divided by the total orders placed in that period. Total orders are the summation of all completed individual purchase transactions in a given period. The Company believes its relatively high average order value demonstrates the premium nature of its products. As the Company expands into and increases its presence in additional product categories, price points and international markets, average order value may fluctuate.

    Active customers as of December 31, 2024 and 2023, respectively, net revenues per active customer as of December 31, 2024 and 2023, respectively, and average order value for the years ended December 31, 2024 and 2023, respectively, are presented below under the heading "Key Operating Metrics."

    About FIGS

    FIGS is a founder-led, direct-to-consumer healthcare apparel and lifestyle brand that seeks to celebrate, empower, and serve current and future generations of healthcare professionals. We create technically advanced apparel and products that feature an unmatched combination of comfort, durability, function, and style. We share stories about healthcare professionals' experiences in ways that inspire them. We build meaningful connections within the healthcare community that we created. Above all, we seek to make an impact for our community, including by advocating for them and always having their backs.

    We serve healthcare professionals in numerous countries in North America, Europe, the Asia Pacific region and the Middle East. We also serve healthcare institutions through our TEAMS platform.

    Forward Looking Statements

    This press release contains various forward-looking statements about the Company within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, that are based on current management expectations, and which involve substantial risks and uncertainties that could cause actual results to differ materially from the results expressed in, or implied by, such forward-looking statements. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking. These forward-looking statements generally are identified by the words "anticipate", "believe", "contemplate", "continue", "could", "estimate", "expect", "forecast", "future", "intend", "may", "might", "opportunity", "outlook", "plan", "possible", "potential", "predict", "project," "should", "strategy", "strive", "target", "will" or "would", the negative of these words or other similar terms or expressions. The absence of these words does not mean that a statement is not forward-looking. These forward-looking statements address various matters, including the Company's expectation that the industry and Company will normalize; the Company's plans to accelerate its strategic pillars to drive long-term sustainable and profitable growth; the Company's confidence in its brand positioning, strategic focus and the long-term structural strength of the healthcare industry; the Company's share repurchase program; the Company's belief that its financial position will support its efforts in 2025; the Company's plans to invest in its emerging channels and opportunities across brand and marketing; the Company's planned reduction in promotions and the expected resulting impact on the business; the Company's efforts to return value to shareholders; the Company's growth ambitions; and the information under the section titled "Full Year 2025 Financial Outlook," such as the Company's outlook as to net revenues growth and adjusted EBITDA margin for the full year ending December 31, 2025; all of which reflect the Company's expectations based upon currently available information and data. Because such statements are based on expectations as to future financial and operating results and are not statements of fact, the Company's actual results, performance or achievements may differ materially from those expressed or implied by the forward-looking statements, and you are cautioned not to place undue reliance on these forward-looking statements. The following important factors and uncertainties, among others, could cause actual results, performance or achievements to differ materially from those described in these forward-looking statements: the Company's ability to maintain its historical growth; the Company's ability to maintain profitability; the Company's ability to maintain the value and reputation of its brand; the Company's ability to attract new customers, retain existing customers, and to maintain or increase sales to those customers; the success of the Company's marketing efforts; the Company's ability to maintain a strong community of engaged customers and Ambassadors; negative publicity related to the Company's marketing efforts or use of social media; the Company's ability to successfully develop and introduce new, innovative and updated products; the competitiveness of the market for healthcare apparel; the Company's ability to maintain its key employees; the Company's ability to attract and retain highly skilled team members; risks associated with expansion into, and conducting business in, international markets; changes in, or disruptions to, the Company's shipping arrangements; the successful operation of the Company's distribution and warehouse management systems; the Company's ability to accurately forecast customer demand, manage its inventory, and plan for future expenses; the impact of changes in consumer confidence, shopping behavior and consumer spending on demand for the Company's products; the impact of macroeconomic trends on the Company's operations; the Company's reliance on a limited number of third-party suppliers; the fluctuating costs of raw materials; the Company's failure to protect proprietary, confidential or sensitive information or personal customer data or risks of cyberattacks; the Company's failure to protect its intellectual property rights; the fact that the operations of many of the Company's suppliers and vendors are subject to additional risks that are beyond its control; and other risks, uncertainties and factors discussed in the "Risk Factors" section of the Company's Annual Report on Form 10-K for the year ended December 31, 2024 to be filed with the Securities and Exchange Commission ("SEC"), and the Company's other periodic filings with the SEC. The forward-looking statements in this press release speak only as of the time made and the Company does not undertake to update or revise them to reflect future events or circumstances.

    FIGS, INC.

    CONSOLIDATED BALANCE SHEETS

    (In thousands, except share and per share data)

     

     

    As of

     

    December 31,

    2024

     

    December 31,

    2023

    Assets

     

     

     

    Current assets

     

     

     

    Cash and cash equivalents

    $

    85,645

     

    $

    144,173

    Short-term investments

     

    159,469

     

     

    102,522

    Accounts receivable

     

    8,625

     

     

    7,469

    Inventory, net

     

    115,759

     

     

    119,040

    Prepaid expenses and other current assets

     

    13,268

     

     

    12,455

    Total current assets

     

    382,766

     

     

    385,659

    Non-current assets

     

     

     

    Property and equipment, net

     

    35,274

     

     

    24,864

    Operating lease right-of-use assets

     

    50,497

     

     

    43,059

    Deferred tax assets

     

    11,643

     

     

    18,291

    Investment in equity securities

     

    27,534

     

     

    —

    Other assets

     

    2,073

     

     

    1,336

    Total non-current assets

     

    127,021

     

     

    87,550

    Total assets

    $

    509,787

     

    $

    473,209

    Liabilities and stockholders' equity

     

     

     

    Current liabilities

     

     

     

    Accounts payable

    $

    9,401

     

    $

    14,749

    Operating lease liabilities

     

    10,596

     

     

    8,230

    Accrued expenses

     

    42,316

     

     

    7,906

    Accrued compensation and benefits

     

    5,689

     

     

    7,312

    Sales tax payable

     

    3,705

     

     

    3,149

    Gift card liability

     

    9,604

     

     

    8,240

    Deferred revenue

     

    4,612

     

     

    2,160

    Returns reserve

     

    3,873

     

     

    2,989

    Income tax payable

     

    346

     

     

    2,557

    Total current liabilities

     

    90,142

     

     

    57,292

    Non-current liabilities

     

     

     

    Operating lease liabilities, non-current

     

    42,430

     

     

    38,884

    Other non-current liabilities

     

    83

     

     

    183

    Total liabilities

     

    132,655

     

     

    96,359

    Commitments and contingencies

     

     

     

    Stockholders' equity

     

     

     

    Class A common stock — par value $0.0001 per share, 1,000,000,000 shares authorized as of December 31, 2024 and December 31, 2023; 154,003,352 and 161,457,403 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively

     

    15

     

     

    16

    Class B common stock — par value $0.0001 per share, 150,000,000 shares authorized as of December 31, 2024 and December 31, 2023; 8,283,641 shares issued and outstanding as of December 31, 2024 and December 31, 2023

     

    —

     

     

    —

    Preferred stock — par value $0.0001 per share, 100,000,000 shares authorized as of December 31, 2024 and December 31, 2023; zero shares issued and outstanding as of December 31, 2024 and December 31, 2023

     

    —

     

     

    —

    Additional paid-in capital

     

    312,622

     

     

    315,075

    Accumulated other comprehensive income

     

    21

     

     

    5

    Retained earnings

     

    64,474

     

     

    61,754

    Total stockholders' equity

     

    377,132

     

     

    376,850

    Total liabilities and stockholders' equity

    $

    509,787

     

    $

    473,209

    FIGS, INC.

    CONSOLIDATED STATEMENTS OF OPERATIONS

    (In thousands, except share and per share data)

     

     

    Three months ended December 31,

     

    Year ended December 31,

     

    2024

     

    2023

     

    2024

     

    2023

     

    (unaudited)

     

     

     

     

    Net revenues

    $

    151,832

     

    $

    144,918

     

     

    $

    555,558

     

    $

    545,646

     

    Cost of goods sold

     

    49,636

     

     

    47,058

     

     

     

    179,935

     

     

    168,683

     

    Gross profit

     

    102,196

     

     

    97,860

     

     

     

    375,623

     

     

    376,963

     

    Operating expenses

     

     

     

     

     

     

     

    Selling

     

    37,917

     

     

    28,057

     

     

     

    141,909

     

     

    125,149

     

    Marketing

     

    19,788

     

     

    20,129

     

     

     

    88,566

     

     

    77,094

     

    General and administrative

     

    35,591

     

     

    35,446

     

     

     

    142,883

     

     

    140,675

     

    Total operating expenses

     

    93,296

     

     

    83,632

     

     

     

    373,358

     

     

    342,918

     

    Net income from operations

     

    8,900

     

     

    14,228

     

     

     

    2,265

     

     

    34,045

     

    Other income, net

     

     

     

     

     

     

     

    Interest income

     

    2,639

     

     

    2,281

     

     

     

    11,242

     

     

    6,775

     

    Other income (expense)

     

    841

     

     

    (2

    )

     

     

    833

     

     

    (13

    )

    Total other income, net

     

    3,480

     

     

    2,279

     

     

     

    12,075

     

     

    6,762

     

    Net income before provision for income taxes

     

    12,380

     

     

    16,507

     

     

     

    14,340

     

     

    40,807

     

    Provision for income taxes

     

    10,495

     

     

    6,507

     

     

     

    11,620

     

     

    18,170

     

    Net income

    $

    1,885

     

    $

    10,000

     

     

    $

    2,720

     

    $

    22,637

     

    Earnings attributable to Class A and Class B common stockholders

     

     

     

     

     

     

     

    Basic earnings per share

    $

    0.01

     

    $

    0.06

     

     

    $

    0.02

     

    $

    0.13

     

    Diluted earnings per share

    $

    0.01

     

    $

    0.05

     

     

    $

    0.02

     

    $

    0.12

     

    Weighted-average shares outstanding—basic

     

    166,343,035

     

     

    169,361,975

     

     

     

    169,201,983

     

     

    168,065,721

     

    Weighted-average shares outstanding—diluted

     

    178,588,552

     

     

    182,000,733

     

     

     

    180,102,840

     

     

    182,412,965

     

    FIGS, INC.

    CONSOLIDATED STATEMENTS OF CASH FLOWS

    (In thousands)

     

     

    Year ended

    December 31,

     

    2024

     

    2023

    Cash flows from operating activities:

     

     

     

    Net income

    $

    2,720

     

     

    $

    22,637

     

    Adjustments to reconcile net income to net cash provided by operating activities:

     

     

     

    Depreciation and amortization expense

     

    6,694

     

     

     

    2,942

     

    Deferred income taxes

     

    6,648

     

     

     

    (7,320

    )

    Non-cash operating lease cost

     

    8,483

     

     

     

    2,863

     

    Stock-based compensation

     

    42,673

     

     

     

    45,799

     

    Accretion of discount on available-for-sale securities

     

    (5,741

    )

     

     

    (1,678

    )

    Changes in operating assets and liabilities:

     

     

     

    Accrued interest

    $

    (758

    )

     

     

    —

     

    Accounts receivable

     

    (1,219

    )

     

     

    (603

    )

    Inventory

     

    3,281

     

     

     

    58,936

     

    Prepaid expenses and other current assets

     

    (2,544

    )

     

     

    (572

    )

    Other assets

     

    (737

    )

     

     

    (79

    )

    Accounts payable

     

    (5,332

    )

     

     

    (6,192

    )

    Accrued expenses

     

    33,950

     

     

     

    (18,657

    )

    Accrued compensation and benefits

     

    (1,623

    )

     

     

    3,897

     

    Sales tax payable

     

    556

     

     

     

    (225

    )

    Gift card liability

     

    1,364

     

     

     

    358

     

    Deferred revenue

     

    2,452

     

     

     

    (626

    )

    Returns reserve

     

    884

     

     

     

    (469

    )

    Income tax payable

     

    (2,211

    )

     

     

    2,557

     

    Operating lease liabilities

     

    (8,278

    )

     

     

    (2,660

    )

    Other non-current liabilities

     

    (100

    )

     

     

    7

     

    Net cash provided by operating activities

     

    81,162

     

     

     

    100,915

     

    Cash flows from investing activities:

     

     

     

    Purchases of property and equipment

     

    (17,021

    )

     

     

    (16,348

    )

    Purchases of available-for-sale securities

     

    (246,949

    )

     

     

    (150,139

    )

    Maturities of available-for-sale securities

     

    196,580

     

     

     

    49,300

     

    Purchase of investment in equity securities

     

    (27,534

    )

     

     

    —

     

    Net cash used in investing activities

     

    (94,924

    )

     

     

    (117,187

    )

    Cash flows from financing activities:

     

     

     

    Repurchases of Class A Common Stock

     

    (45,454

    )

     

     

    —

     

    Proceeds from stock option exercises and employee stock purchases

     

    438

     

     

     

    916

     

    Tax payments related to net share settlements on restricted stock units

     

    —

     

     

     

    (246

    )

    Issuance of Class A Common Stock in exchange for services

     

    250

     

     

     

    —

     

    Net cash (used in) provided by financing activities

     

    (44,766

    )

     

     

    670

     

    Net decrease in cash, cash equivalents, and restricted cash

     

    (58,528

    )

     

     

    (15,602

    )

    Cash, cash equivalents, and restricted cash, beginning of period

    $

    144,173

     

     

    $

    159,775

     

    Cash and cash equivalents, end of period

    $

    85,645

     

     

    $

    144,173

     

    FIGS, INC.

    RECONCILIATIONS OF GAAP TO NON-GAAP MEASURES

    (Unaudited)

    The following table presents a reconciliation of net income, as adjusted to net income, which is the most directly comparable financial measure calculated in accordance with GAAP, and presents diluted earnings per share ("EPS"), as adjusted with diluted EPS:

     

    Three Months Ended

    December 31,

     

     

    Year Ended

    December 31,

     

    2024

     

    2023

     

     

    2024

     

    2023

     

     

     

     

     

     

     

     

     

     

     

    (in thousands, except share and per share data)

    Net income

    $

    1,885

     

    $

    10,000

     

     

    $

    2,720

     

    $

    22,637

     

    Add (deduct):

     

     

     

     

     

     

     

     

    Expenses related to non-ordinary course disputes(1)

     

    —

     

     

    —

     

     

     

    —

     

     

    1,256

     

    Stock-based compensation expense in connection with the IPO and other(2)

     

    —

     

     

    —

     

     

     

    —

     

     

    290

     

    Income tax impacts of items above

     

    —

     

     

    —

     

     

     

    —

     

     

    (847

    )

    Net income, as adjusted

    $

    1,885

     

    $

    10,000

     

     

    $

    2,720

     

    $

    23,336

     

    Diluted EPS

    $

    0.01

     

    $

    0.05

     

     

    $

    0.02

     

    $

    0.12

     

    Diluted EPS, as adjusted

    $

    0.01

     

    $

    0.05

     

     

    $

    0.02

     

    $

    0.13

     

    Weighted-average shares used to compute Diluted EPS, as adjusted

     

    178,588,552

     

     

    182,000,733

     

     

     

    180,102,840

     

     

    182,412,965

    (1)

     

    Exclusively represents attorney's fees, costs and expenses incurred by the Company in connection with the Company's now-concluded litigation against Strategic Partners, Inc.

    (2)

     

    Includes certain stock-based compensation expense in connection with the IPO, including expense related to accelerated performance awards and associated payroll taxes and costs.

    The following table presents a reconciliation of adjusted EBITDA to net income, which is the most directly comparable financial measure calculated in accordance with GAAP, and presents adjusted EBITDA margin with net income margin, which is the most directly comparable financial measure calculated in accordance with GAAP:

     

    Three Months Ended

    December 31,

     

     

    Year Ended

    December 31,

     

    2024

     

    2023

     

     

    2024

     

    2023

     

    (in thousands, except margin)

    Net income

    $

    1,885

     

     

    $

    10,000

     

     

     

    $

    2,720

     

     

    $

    22,637

     

    Add (deduct):

     

     

     

     

     

     

     

     

    Other income, net

     

    (3,481

    )

     

     

    (2,279

    )

     

     

     

    (12,075

    )

     

     

    (6,762

    )

    Provision for income taxes

     

    10,494

     

     

     

    6,506

     

     

     

     

    11,620

     

     

     

    18,170

     

    Depreciation and amortization expense(1)

     

    1,847

     

     

     

    814

     

     

     

     

    6,694

     

     

     

    2,942

     

    Stock-based compensation and related expense(2)

     

    10,331

     

     

     

    11,562

     

     

     

     

    42,837

     

     

     

    47,757

     

    Expenses related to non-ordinary course disputes(3)

     

    —

     

     

     

    —

     

     

     

     

    —

     

     

     

    1,256

     

    Adjusted EBITDA

    $

    21,076

     

     

    $

    26,603

     

     

     

    $

    51,796

     

     

    $

    86,000

     

     

     

     

     

     

     

     

     

     

    Net Revenues

    $

    151,832

     

     

    $

    144,918

     

     

     

    $

    555,558

     

     

    $

    545,646

     

    Net income margin(4)

     

    1.2

    %

     

     

    6.9

    %

     

     

     

    0.5

    %

     

     

    4.1

    %

    Adjusted EBITDA Margin

     

    13.9

    %

     

     

    18.4

    %

     

     

     

    9.3

    %

     

     

    15.8

    %

    (1)

     

    Excludes amortization of debt issuance costs included in "Other income, net."

    (2)

     

    Includes stock-based compensation expense, payroll taxes, and costs related to equity award activity.

    (3)

     

    Exclusively represents attorney's fees, costs and expenses incurred by the Company in connection with the Company's now-concluded litigation against Strategic Partners, Inc.

    (4)

     

    Net income margin represents net income as a percentage of net revenues.

    The following table presents a reconciliation of free cash flow to net cash provided by operating activities, which is the most directly comparable financial measure calculated in accordance with GAAP:

     

    Year ended

    December 31,

     

    2024

     

    2023

     

    (in thousands)

    Net cash provided by operating activities

    $

    81,162

     

     

    $

    100,915

     

    Less: capital expenditures

     

    (17,021

    )

     

     

    (16,348

    )

    Free cash flow

    $

    64,141

     

     

    $

    84,567

     

    FIGS, INC.

    KEY OPERATING METRICS

    (Unaudited)

    Active customers as of December 31, 2024 and 2023, respectively, net revenues per active customer as of December 31, 2024 and 2023, respectively, and average order value for the year ended December 31, 2024 and 2023, respectively, are presented in the following tables:

     

    As of December 31,

     

    2024

     

    2023

     

    (in thousands)

    Active customers

    2,670

     

    2,593

     

    As of December 31,

     

    2024

     

    2023

    Net revenues per active customer

    $

    208

     

    $

    210

     

    Year ended

    December 31,

     

    2024

     

    2023

    Average order value

    $

    113

     

    $

    115

    FIGS, INC.

    DISAGGREGATED NET REVENUES

    (In thousands, except percentages)

    The following table presents the disaggregation of the Company's net revenues for the year and three months ended December 31, 2024 and December 31, 2023:

     

    Year ended

    December 31,

     

    Change

     

    2024

     

    2023

     

    %

    By geography:

     

     

     

     

     

    United States

    $

    474,305

     

    $

    483,454

     

    (1.9

    )%

    Rest of the world

     

    81,253

     

     

    62,192

     

    30.6

    %

     

    $

    555,558

     

    $

    545,646

     

    1.8

    %

    By product:

     

     

     

     

     

    Scrubwear

    $

    445,112

     

    $

    439,987

     

    1.2

    %

    Non-Scrubwear

     

    110,446

     

     

    105,659

     

    4.5

    %

     

    $

    555,558

     

    $

    545,646

     

    1.8

    %

     

    Three months ended

    December 31,

     

    Change

     

    2024

     

    2023

     

    %

     

    (Unaudited)

    By geography:

     

     

     

     

     

    United States

    $

    127,503

     

    $

    128,159

     

    (0.5

    )%

    Rest of the world

     

    24,328

     

    $

    16,759

     

    45.2

    %

     

    $

    151,831

     

    $

    144,918

     

    4.8

    %

    By product:

     

     

     

     

     

    Scrubwear

    $

    114,652

     

    $

    111,956

     

    2.4

    %

    Non-Scrubwear

     

    37,179

     

    $

    32,962

     

    12.8

    %

     

    $

    151,831

     

    $

    144,918

     

    4.8

    %

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250227612005/en/

    Contacts

    Investors:

    Tom Shaw

    [email protected]

    Media:

    Todd Maron

    [email protected]

    Get the next $FIGS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $FIGS

    DatePrice TargetRatingAnalyst
    5/5/2025$7.00 → $5.00Market Perform
    Telsey Advisory Group
    8/9/2024$6.00 → $7.00Market Perform
    Telsey Advisory Group
    4/2/2024$8.50 → $4.50Neutral → Underperform
    BofA Securities
    3/8/2024Outperform → Perform
    Oppenheimer
    2/29/2024$6.00Outperform → Market Perform
    Telsey Advisory Group
    1/24/2024$7.00Underweight → Equal Weight
    Barclays
    7/17/2023Outperform → Mkt Perform
    Raymond James
    5/3/2023$9.00Buy
    ROTH MKM
    More analyst ratings

    $FIGS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • FIGS Releases First Quarter 2025 Financial Results

      Results Exceed Expectations Highlighted by Net Revenues Growth of 4.7% Updates Full Year 2025 Outlook in Response to U.S. Tariffs FIGS, Inc. (NYSE:FIGS) (the "Company"), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its first quarter 2025 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/. First Quarter 2025 Financial Highlights Net revenues were $124.9 million, an increase of 4.7% year over year, primarily due to an increase in orders from existing customers and higher average order value ("AOV"). Scrubwear net

      5/8/25 4:05:00 PM ET
      $FIGS
      Apparel
      Consumer Discretionary
    • Jeffrey Lawrence Appointed Chairman of Joe & the Juice

      Joe & the Juice ("the Company"), an urban juice bar and coffee concept selling freshly prepared juices, coffee, sandwiches and more, today announced that Jeffrey Lawrence, a member of the Company's Board of Directors since April 2024, has been appointed as Chairman of the Board. Thomas Nørøxe, Chief Executive Officer of Joe & the Juice, said, "Jeff's elevation to Chairman of Joe & the Juice reflects how his active participation has made a material difference to the Company's performance and strategy. Over the past year, Joe & the Juice has achieved continued impressive same store sales and revenue growth as we also opened our 400th unit globally. Unit economics remain incredibly strong and

      4/24/25 3:00:00 AM ET
      $DPZ
      $FIGS
      $SHAK
      $XPOF
      Food Distributors
      Consumer Discretionary
      Apparel
      Restaurants
    • FIGS Announces Date of First Quarter 2025 Earnings Release, Conference Call and Webcast

      FIGS, Inc. (NYSE:FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced it will release its first quarter 2025 financial results on Thursday, May 8, 2025, after U.S. markets close. FIGS management will host a conference call that day at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial and business results and outlook. Prior to the call, FIGS will publish a first quarter 2025 financial highlights presentation on its investor relations website at https://ir.wearfigs.com/financials/quarterly-results/default.aspx. FIGS First Quarter 2025 Earnings and Conference Call Date: Thursday, May 8, 2025 Time: 2:00 p.m. PT /

      4/17/25 4:05:00 PM ET
      $FIGS
      Apparel
      Consumer Discretionary

    $FIGS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Telsey Advisory Group reiterated coverage on FIGS, Inc. with a new price target

      Telsey Advisory Group reiterated coverage of FIGS, Inc. with a rating of Market Perform and set a new price target of $5.00 from $7.00 previously

      5/5/25 7:49:12 AM ET
      $FIGS
      Apparel
      Consumer Discretionary
    • Telsey Advisory Group reiterated coverage on FIGS, Inc. with a new price target

      Telsey Advisory Group reiterated coverage of FIGS, Inc. with a rating of Market Perform and set a new price target of $7.00 from $6.00 previously

      8/9/24 8:23:13 AM ET
      $FIGS
      Apparel
      Consumer Discretionary
    • FIGS, Inc. downgraded by BofA Securities with a new price target

      BofA Securities downgraded FIGS, Inc. from Neutral to Underperform and set a new price target of $4.50 from $8.50 previously

      4/2/24 7:31:13 AM ET
      $FIGS
      Apparel
      Consumer Discretionary

    $FIGS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Jao Hsiao Yueh was granted 5,923 shares, increasing direct ownership by 13% to 52,851 units (SEC Form 4)

      4 - FIGS, Inc. (0001846576) (Issuer)

      4/3/25 4:50:55 PM ET
      $FIGS
      Apparel
      Consumer Discretionary
    • New insider Jao Hsiao Yueh claimed ownership of 46,928 shares (SEC Form 3)

      3 - FIGS, Inc. (0001846576) (Issuer)

      4/3/25 4:48:23 PM ET
      $FIGS
      Apparel
      Consumer Discretionary
    • SEC Form 4 filed by Director Whelan Melanie Anya

      4 - FIGS, Inc. (0001846576) (Issuer)

      3/31/25 4:42:46 PM ET
      $FIGS
      Apparel
      Consumer Discretionary

    $FIGS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by FIGS Inc.

      SC 13G/A - FIGS, Inc. (0001846576) (Subject)

      11/14/24 1:28:33 PM ET
      $FIGS
      Apparel
      Consumer Discretionary
    • SEC Form SC 13G filed by FIGS Inc.

      SC 13G - FIGS, Inc. (0001846576) (Subject)

      11/14/24 12:17:49 PM ET
      $FIGS
      Apparel
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by FIGS Inc.

      SC 13G/A - FIGS, Inc. (0001846576) (Subject)

      11/13/24 10:27:59 AM ET
      $FIGS
      Apparel
      Consumer Discretionary

    $FIGS
    Financials

    Live finance-specific insights

    See more
    • FIGS Releases First Quarter 2025 Financial Results

      Results Exceed Expectations Highlighted by Net Revenues Growth of 4.7% Updates Full Year 2025 Outlook in Response to U.S. Tariffs FIGS, Inc. (NYSE:FIGS) (the "Company"), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its first quarter 2025 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/. First Quarter 2025 Financial Highlights Net revenues were $124.9 million, an increase of 4.7% year over year, primarily due to an increase in orders from existing customers and higher average order value ("AOV"). Scrubwear net

      5/8/25 4:05:00 PM ET
      $FIGS
      Apparel
      Consumer Discretionary
    • FIGS Announces Date of First Quarter 2025 Earnings Release, Conference Call and Webcast

      FIGS, Inc. (NYSE:FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced it will release its first quarter 2025 financial results on Thursday, May 8, 2025, after U.S. markets close. FIGS management will host a conference call that day at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial and business results and outlook. Prior to the call, FIGS will publish a first quarter 2025 financial highlights presentation on its investor relations website at https://ir.wearfigs.com/financials/quarterly-results/default.aspx. FIGS First Quarter 2025 Earnings and Conference Call Date: Thursday, May 8, 2025 Time: 2:00 p.m. PT /

      4/17/25 4:05:00 PM ET
      $FIGS
      Apparel
      Consumer Discretionary
    • FIGS Announces Date of Fourth Quarter and Full Year 2024 Earnings Release, Conference Call and Webcast

      FIGS, Inc. (NYSE:FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced it will release its fourth quarter and full year 2024 financial results on Thursday, February 27, 2025, after U.S. markets close. FIGS management will host a conference call that day at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial and business results and outlook. Prior to the call, FIGS will publish a fourth quarter and full year 2024 financial highlights presentation on its investor relations website at https://ir.wearfigs.com/financials/quarterly-results/default.aspx. FIGS Fourth Quarter and Full Year 2024 Earnings and Conference Call

      2/6/25 4:05:00 PM ET
      $FIGS
      Apparel
      Consumer Discretionary

    $FIGS
    SEC Filings

    See more
    • SEC Form 10-Q filed by FIGS Inc.

      10-Q - FIGS, Inc. (0001846576) (Filer)

      5/8/25 4:46:53 PM ET
      $FIGS
      Apparel
      Consumer Discretionary
    • FIGS Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - FIGS, Inc. (0001846576) (Filer)

      5/8/25 4:38:45 PM ET
      $FIGS
      Apparel
      Consumer Discretionary
    • SEC Form DEFA14A filed by FIGS Inc.

      DEFA14A - FIGS, Inc. (0001846576) (Filer)

      4/24/25 4:46:56 PM ET
      $FIGS
      Apparel
      Consumer Discretionary

    $FIGS
    Leadership Updates

    Live Leadership Updates

    See more
    • FIGS Adds Digital Marketing Executive Jerry Jao as New Independent Director to Its Board of Directors

      FIGS, Inc. (NYSE:FIGS) (the "Company"), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced the appointment of Jerry Jao, former Chief Executive Officer of Retention Science, to its board of directors (the "Board"), effective April 1, 2025 (the "Effective Date"). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250403714974/en/Jerry Jao Mr. Jao joins the Board as an independent director and has also been appointed to serve as both Chair of the Board's Audit Committee and as a member of the Board's Compensation Committee. Since May 2024, Mario Marte has served as

      4/3/25 8:00:00 AM ET
      $FIGS
      Apparel
      Consumer Discretionary
    • FIGS Announces Updates to Board of Directors

      FIGS, Inc. (NYSE:FIGS) (the "Company"), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced the appointment of Melanie Whelan, former Chief Executive Officer of SoulCycle Inc., to its board of directors (the "Board"), effective January 1, 2025 (the "Effective Date"). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241219372097/en/Melanie Whelan (Photo: Business Wire) Ms. Whelan joins the Board as an independent director. Ms. Whelan has also been appointed to serve as Chair of the Board's Compensation Committee, which as of the Effective Date will consist of Ms.

      12/19/24 6:50:00 AM ET
      $FIGS
      Apparel
      Consumer Discretionary
    • Sarah Oughtred to Become FIGS' New Chief Financial Officer

      Longtime Senior Finance Executive Joins FIGS After Almost 17 Years at lululemon FIGS, Inc. (NYSE:FIGS), the renowned medical apparel brand, today announced the appointment of Sarah Oughtred as the Company's new Chief Financial Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240612619238/en/(Photo: Business Wire) To facilitate a smooth transition, Ms. Oughtred will join FIGS on July 29, 2024, and will become FIGS' Chief Financial Officer, effective August 9, 2024. Ms. Oughtred will lead all aspects of finance, including FP&A and accounting, and will also lead data analytics. "I am thrilled to welcome Sarah to FIGS dur

      6/12/24 6:50:00 AM ET
      $FIGS
      Apparel
      Consumer Discretionary